Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Absence of cardiodepressive effects with beraprost

July 13, 1998

Cor Therapeutics patents novel factor Xa inhibitors

July 9, 1998

Abciximab treatment validated for prevention of ischemic complications after coronary intervention

July 9, 1998

Cor Therapeutics describes selective factor Xa inhibitors

July 8, 1998

Platelet aggregation inhibitors in development at Meiji Seika

July 6, 1998

FDA advisory committee to review Pletal NDA next week

July 3, 1998

Zeria discloses new thromboxane antagonists for thrombosis

July 3, 1998

HMR introduces Refludan in U.S.

July 2, 1998

Factor Xa inhibitors developed by Boehringer Mannheim researchers

June 30, 1998

RPR acquires worldwide rights to Novartis anticoagulant

June 29, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...